TITLE

Glucose and insulin after diet and tolazamide treatment

AUTHOR(S)
Sheldon, J.
PUB. DATE
October 1970
SOURCE
British Medical Journal;10/24/1970, Vol. 4 Issue 5729, p246
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098329

 

Related Articles

  • Tolazamide.  // AHFS Consumer Medication Information;Oct2019, p1 

    Tolazamide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Tolazamide is in a class of medications called...

  • Effects of sulfonylureas,α-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes. Biederman, Jason I.; Vera, Edgard; Rankhaniya, Rohit; Hassett, Clare; Giannico, Giovanna; Yee, Jerry; Cortes, Pedro // Kidney International;Feb2005, Vol. 67 Issue 2, p554 

    Effects of sulfonylureas,α-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes.Background.Previously, we showed the expression of a unique sulfonylurea receptor (SUR) and its putative endogenous ligand,α-endosulfine, in mesangial cells and isolated...

  • Effects of Sleep Restriction on Glucose Control and Insulin Secretion During Diet-Induced Weight Loss. Nedeltcheva, Arlet V.; Imperial, Jacqueline G.; Penev, Plamen D. // Obesity (19307381);Jul2012, Vol. 20 Issue 7, p1379 

    Insufficient sleep is associated with changes in glucose tolerance, insulin secretion, and insulin action. Despite widespread use of weight-loss diets for metabolic risk reduction, the effects of insufficient sleep on glucose regulation in overweight dieters are not known. To examine the...

  • Therapeutic Management of Diabetes mellitus with Dermatological affection in a bitch. Das, Mousam; Konar, Sabyasachi; Pradhan, N. R. // Intas Polivet;Jul-Dec2013, Vol. 14 Issue 2, p445 

    Type I diabetes mellitus in a Chihuahua bitch was observed with lethergy, polydipsia, polyuria, persistent hyperglycaemia, glycosuria and ketonuria along with skin infection. Diagnosis was done by history, clinical signs and symptoms and laboratory results. Fasting blood glucose and insulin were...

  • Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice. Rancoule, C.; Attané, C.; Grès, S.; Fournel, A.; Dusaulcy, R.; Bertrand, C.; Vinel, C.; Tréguer, K.; Prentki, M.; Valet, P.; Saulnier-Blache, J. // Diabetologia;Jun2013, Vol. 56 Issue 6, p1394 

    Aims/hypothesis: Lysophosphatidic acid (LPA) is a lipid mediator produced by adipocytes that acts via specific G-protein-coupled receptors; its synthesis is modulated in obesity. We previously reported that reducing adipocyte LPA production in high-fat diet (HFD)-fed obese mice is associated...

  • Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Gannon, Mary C.; Nuttall, Frank Q. // Nutrition & Metabolism;2006, Vol. 3, p16 

    Background: Over the past several years our research group has taken a systematic, comprehensive approach to determining the effects on body function (hormonal and nonhormonal) of varying the amounts and types of proteins, carbohydrates and fats in the diet. We have been particularly interested...

  • Successful islet autotransplantation in humans. Teuscher, Adrian U.; Kendall, David M.; Smets, Yves F.C.; Leone, John P.; Sutherland, David E.R.; Robertson, R. Paul // Diabetes;Mar1998, Vol. 47 Issue 3, p324 

    Presents studies of glucose potentiation of arginine-induced insulin secretion (GPAIS) in recipients of intrahepatic islet autotransplants to determine insulin secretory reserve after islet cell transplant. Establishment of normoglycemia and phasic insulin secretion; Reduction of acute insulin...

  • Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer's disease mouse model. Kunath, Nicolas; van Groen, Thomas; Allison, David B.; Kumar, Ashish; Dozier-Sharpe, Monique; Kadish, Inga // Scientific Reports;6/19/2015, p11452 

    The orexigenic hormone ghrelin, a potential antagonist of the insulin system, ensures sufficient serum glucose in times of fasting. In the race for new therapeutics for diabetes, one focus of study has been antagonizing the ghrelin system in order to improve glucose tolerance. We provide...

  • Role of Hypovitaminosis D in the Incidence and Complications of Diabetes Mellitus in Rats. EL-Sayed, Hanaa H.; El-Adawy, Ayman E.; Yassin, Areej A.; Mostafa, Soad H. // Egyptian Journal of Hospital Medicine;Jan2016, Vol. 62, p77 

    Background: Diabetes mellitus continues to be a public health concern. Vitamin D had sparked widespread interest in the pathogenesis and prevention of diabetes. The aim of this study was to investigate the effect of vitamin D (deficiency & treatment) with alteration in fasting plasma glucose,...

  • Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment. Saleh, N.; Petursson, P.; Lagerqvist, B.; Skúladóttir, H.; Svensson, A.; Eliasson, B.; Gudbjörnsdottir, S.; Eeg-Olofsson, K.; Norhammar, A. // Diabetologia;Aug2012, Vol. 55 Issue 8, p2109 

    Aims/hypothesis: The aim of this study was to analyse whether the increased mortality rates observed in insulin-treated patients with type 2 diabetes and coronary artery disease are explained by comorbidities and complications. Methods: A retrospective analysis of data from two Swedish...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics